EX-99.1 2 ex991.htm EX-99.1 Document

JOHN WILEY & SONS, INC.
REVISED SEGMENT RESULTS (1)
(in thousands)
(unaudited)

Q123Q223
Research (2):
  
Revenue, net  
Research Publishing$239,523 $232,641 
Research Solutions35,390 38,718 
Total Revenue, net$274,913 $271,359 
Contribution to Profit$69,023 $73,279 
Adjustments:
Restructuring charges81 1,179 
Non-GAAP Adjusted Contribution to Profit $69,104 $74,458 
Depreciation and amortization23,801 23,384 
Non-GAAP Adjusted EBITDA$92,905 $97,842 
Academic:
Revenue, net  
Academic Publishing$104,366 $121,798 
University Services46,771 57,170 
Total Revenue, net$151,137 $178,968 
Contribution to Profit$(21,121)$23,385 
Adjustments:
Restructuring charges 4,167 4,073 
Non-GAAP Adjusted Contribution to Profit$(16,954)$27,458 
Depreciation and amortization20,919 20,706 
Non-GAAP Adjusted EBITDA$3,965 $48,164 
Talent:
Total Revenue, net$61,519 $64,509 
Contribution to Profit$(463)$13,108 
Adjustments:
Restructuring charges (credits) 2,456 (128)
Accelerated amortization of an intangible asset (3)
4,594 — 
Non-GAAP Adjusted Contribution to Profit$6,587 $12,980 
Depreciation and amortization4,809 4,421 
Non-GAAP Adjusted EBITDA$11,396 $17,401 
Corporate Expenses:$(64,404)$(52,333)
Adjustments:
Restructuring charges 15,737 8,832 
Non-GAAP Adjusted Contribution to Profit$(48,667)$(43,501)
Depreciation and amortization4,156 3,910 
Non-GAAP Adjusted EBITDA$(44,511)$(39,591)
Consolidated Results:  
Revenue, net$487,569 $514,836 
Operating (Loss) Income$(16,965)$57,439 
Adjustments:
Restructuring charges22,441 13,956 
Accelerated amortization of an intangible asset (3)
4,594 — 
Non-GAAP Adjusted Operating Income$10,070 $71,395 
Depreciation and amortization53,685 52,421 
Non-GAAP Adjusted EBITDA$63,755 $123,816 
Notes:
(1) All amounts are approximate due to rounding.
(2) The Research segment was previously referred to as Research Publishing & Platforms.
(3) On January 1, 2020, Wiley acquired mthree, a talent placement provider that addresses the IT skills gap by finding, training, and placing job-ready technology talent in roles with leading corporations worldwide. Its results of operations are included in our Talent segment. In late May 2022, Wiley renamed the mthree talent development solution to Wiley Edge and discontinued use of the mthree trademark during the three months ended July 31, 2022. As a result of these actions, we determined that a revision of the useful life was warranted, and the intangible asset was fully amortized over its remaining useful life resulting in accelerated amortization expense of $4.6 million in the three months ended July 31, 2022.



JOHN WILEY & SONS, INC.
REVISED SEGMENT RESULTS (1)
(in thousands)
(unaudited)

Q122Q222Q322Q422FY22FY21
Research (2):
  
Revenue, net  
Research Publishing (3)
$243,284 $238,853 $224,553 $257,025 $963,715 $892,176 
Research Solutions (3)
31,472 36,301 38,788 41,067 147,628 123,173 
Total Revenue, net$274,756 $275,154 $263,341 $298,092 $1,111,343 $1,015,349 
Contribution to Profit$78,808 $77,031 $62,165 $76,985 $294,989 $273,059 
Adjustments:
Restructuring charges (credits)215 22 — — 237 (36)
Non-GAAP Adjusted Contribution to Profit $79,023 $77,053 $62,165 $76,985 $295,226 $273,023 
Depreciation and amortization23,762 23,464 23,914 23,759 94,899 83,866 
Non-GAAP Adjusted EBITDA$102,785 $100,517 $86,079 $100,744 $390,125 $356,889 
Academic:
Revenue, net   
Academic Publishing$110,751 $146,406 $143,583 $130,965 $531,705 $538,643 
University Services54,959 58,608 55,435 58,405 227,407 230,371 
Total Revenue, net$165,710 $205,014 $199,018 $189,370 $759,112 $769,014 
Contribution to Profit$2,035 $35,429 $31,711 $22,542 $91,717 $113,548 
Adjustments:
Restructuring (credits) charges(138)(470)261 (123)(470)3,457 
Non-GAAP Adjusted Contribution to Profit$1,897 $34,959 $31,972 $22,419 $91,247 $117,005 
Depreciation and amortization20,718 21,211 19,693 20,099 81,721 77,823 
Non-GAAP Adjusted EBITDA$22,615 $56,170 $51,665 $42,518 $172,968 $194,828 
Talent:
Total Revenue, net$47,922 $52,835 $53,525 $58,191 $212,473 $157,138 
Contribution to Profit$4,290 $6,363 $5,717 $7,566 $23,936 $(4,731)
Adjustments:
Restructuring charges (credits)275 11 (41)(221)24 577 
Non-GAAP Adjusted Contribution to Profit$4,565 $6,374 $5,676 $7,345 $23,960 $(4,154)
Depreciation and amortization5,949 5,750 5,605 4,693 21,997 23,828 
Non-GAAP Adjusted EBITDA$10,514 $12,124 $11,281 $12,038 $45,957 $19,674 
Corporate Expenses:$(44,165)$(44,935)$(53,604)$(48,662)$(191,366)$(196,365)
Adjustments:
Restructuring (credits) charges(629)(896)228 79 (1,218)29,312 
Non-GAAP Adjusted Contribution to Profit$(44,794)$(45,831)$(53,376)$(48,583)$(192,584)$(167,053)
Depreciation and amortization4,137 4,130 4,151 4,135 16,553 14,672 
Non-GAAP Adjusted EBITDA$(40,657)$(41,701)$(49,225)$(44,448)$(176,031)$(152,381)
Consolidated Results:   
Revenue, net$488,388 $533,003 $515,884 $545,653 $2,082,928 $1,941,501 
Operating Income$40,968 $73,888 $45,989 $58,431 $219,276 $185,511 
Adjustments:
Restructuring (credits) charges(277)(1,333)448 (265)(1,427)33,310 
Non-GAAP Adjusted Operating Income$40,691 $72,555 $46,437 $58,166 $217,849 $218,821 
Depreciation and amortization54,566 54,555 53,363 52,686 215,170 200,189 
Non-GAAP Adjusted EBITDA$95,257 $127,110 $99,800 $110,852 $433,019 $419,010 
Notes:
(1) All amounts are approximate due to rounding.                                                    
(2) The Research segment was previously referred to as Research Publishing & Platforms.
(3) As previously announced in May 2022, our revenue by product type previously referred to as Research Platforms was changed to Research Solutions. Research Solutions includes infrastructure and publishing services that help societies and corporations thrive in a complex knowledge ecosystem. In addition to Platforms (Atypon), certain product offerings such as corporate sales which included the recent acquisitions of Madgex Holdings Limited (Madgex), and Bio-Rad Laboratories Inc.’s Informatics products (Informatics) that were previously included in Research Publishing moved to Research Solutions to align with our strategic focus. Research Solutions also includes product offerings related to certain recent acquisitions such as J&J, and EJP. Prior period results have been revised to the new presentation. There were no changes to the total Research segment or our consolidated financial results. The revenue was $20.1 million, $24.0 million, $24.3 million, and $24.9 million for the three months ended July 31, 2021, October 31, 2021, January 31, 2022, and April 30, 2022, respectively. The revenue was $93.3 million and $80.3 million for the years ended April 30, 2022 and 2021, respectively.